Dorzolamide HCl (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Dorzolamide HCl drug offered from Actavis Pharma, Inc.. This Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | Dorzolamide Hydrochloride |
| SUBSTANCE NAME: | DORZOLAMIDE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-02-17 |
| END MARKETING DATE: | 0000-00-00 |
Dorzolamide HCl HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dorzolamide HCl from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 2015-02-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0591-2481_af92f101-71d4-4f76-86eb-c5bf8479a4e7 |
| PRODUCT NDC: | 0591-2481 |
| APPLICATION NUMBER: | ANDA202053 |
Other DORZOLAMIDE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
